Medication info
Telmisartan/Hydrochlorothiazide Tablet 40/12.5 mg

Telmisartan/Hydrochlorothiazide Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex, round tablet
Packaging
30 tablets (10 tablets/PTPX3), 100 tablets/bottle
Approval status
Active

MFDS item code 201805145 · Approved 2018.12.18 · Insurance code 649807360

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this fixed-dose combination, it is recommended that the doses of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this product may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this product. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this product to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This product should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this product per day. This product should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.
Child dose
The safety and efficacy of this product have not been established in children under 18 years of age.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to help effectively lower and control blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control when telmisartan is used alone.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this fixed-dose combination, it is recommended that the doses of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this product may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this product. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this product to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This product should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this product per day. This product should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.

Child dose

The safety and efficacy of this product have not been established in children under 18 years of age.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to any components or excipients, hypersensitivity to sulfonamide drugs, pregnant or nursing women, patients with bile duct obstruction or cholestasis, severe liver disease, severe kidney disease, acute glomerulonephritis, anuria, and specific electrolyte disturbances. Elderly patients, patients with hyperkalemia, mild to moderate liver dysfunction, valvular heart disease, ischemic heart disease, etc., should use this medication with caution and patients at risk of skin cancer should have their skin condition regularly checked. This medication can cause various adverse reactions, including dizziness, hypotension, gastrointestinal disturbances, skin rash, myalgia, etc., so any symptoms should be reported to a doctor immediately. This medication may interact with other drugs, so it is important to inform your doctor or pharmacist if you are taking other medications, especially when combined with lithium, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs, etc. Women who are pregnant or planning to become pregnant should not use this medication, and it should not be taken while breastfeeding. In cases of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, and immediate medical attention is necessary, with treatment provided according to the symptoms. The safety and efficacy of this medication have not been established in children under 18 years old, so its use is not recommended. Elderly patients should be careful to avoid excessive blood pressure reduction when taking this medication. This medication should be stored out of reach of children and should be removed from the sealed package right before use.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 114 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • lung inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • distention
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic injury
  • angioedema
  • erythema
  • pruritus
  • rash
  • sweating
  • urticaria
  • low back pain
  • muscle cramp
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • elevated blood uric acid
  • increased blood creatinine
  • elevated serum creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • interstitial lung disease
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • asthenia
  • influenza-like illness
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • aplastic anemia
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • asthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • lethargy
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • floating sensation
  • lip and hand tremors
  • sensory hyperesthesia
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is recommended to store it at room temperature, between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, biconvex, round tablet

Package unit

30 tablets (10 tablets/PTPX3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.